Literature DB >> 17108976

Drug discovery through industry-academic partnerships.

Nathanael S Gray1.   

Abstract

Mesh：

Year:  2006        PMID： 17108976     DOI： 10.1038/nchembio1206-649

Source DB:  PubMed          Journal:  Nat Chem Biol        ISSN： 1552-4450            Impact factor:   15.040


× No keyword cloud information.
  5 in total

1.  Drug Discovery in Academia- the third way?

Authors:  Julie Frearson; Paul Wyatt
Journal:  Expert Opin Drug Discov       Date:  2010-10-01       Impact factor: 6.098

2.  Mary S. Easton Center of Alzheimer's Disease Research at UCLA: advancing the therapeutic imperative.

Authors:  Jeffrey L Cummings; John Ringman; Karen Metz
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 3.  Open access high throughput drug discovery in the public domain: a Mount Everest in the making.

Authors:  Anuradha Roy; Peter R McDonald; Sitta Sittampalam; Rathnam Chaguturu
Journal:  Curr Pharm Biotechnol       Date:  2010-11       Impact factor: 2.837

Review 4.  A robotic platform for quantitative high-throughput screening.

Authors:  Sam Michael; Douglas Auld; Carleen Klumpp; Ajit Jadhav; Wei Zheng; Natasha Thorne; Christopher P Austin; James Inglese; Anton Simeonov
Journal:  Assay Drug Dev Technol       Date:  2008-10       Impact factor: 1.738

5.  Academia-industry symbiosis in organic chemistry.

Authors:  Quentin Michaudel; Yoshihiro Ishihara; Phil S Baran
Journal:  Acc Chem Res       Date:  2015-02-23       Impact factor: 22.384
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.